Maeda, Sachi
Ohka, Fumiharu
Okuno, Yusuke
Aoki, Kosuke
Motomura, Kazuya
Takeuchi, Kazuhito
Kusakari, Hironao
Yanagisawa, Nobuyuki
Sato, Shinya
Yamaguchi, Junya
Tanahashi, Kuniaki
Hirano, Masaki
Kato, Akira
Shimizu, Hiroyuki
Kitano, Yotaro
Yamazaki, Shintaro
Yamashita, Shinji
Takeshima, Hideo
Shinjo, Keiko
Kondo, Yutaka
Wakabayashi, Toshihiko
Natsume, Atsushi
Funding for this research was provided by:
Japan Society for the Promotion of Science (19K09478, 17928985)
Article History
Received: 3 December 2019
Accepted: 18 January 2020
First Online: 5 February 2020
Ethics approval and consent to participate
: The present study was approved by the institutional review board at Nagoya University Hospital (approval number: 2012–0067) and it complied with all provisions of the World Medical Association Declaration of Helsinki. Tumor samples of sequential diffuse midline glioma, H3 K27M-mutant cases that had undergone biopsy from February 2014 to March 2019 were collected intra-operatively upon receiving informed consent from the patients.
: Not applicable.
: The authors declare that they have no competing interests.